Shanghai Municipal Health Bureau Confirms Avastin Not Approved For Eye Disorders
This article was originally published in PharmAsia News
Executive Summary
Shanghai Municipal Health Bureau confirmed that of 116 patients who were given Roche's injectable treatment Avastin for eye disorders, 61 patients experienced adverse side effects, including eye redness, blurred vision and in some cases near blindness